Publications by authors named "Y Neuzillet"

Claim this Profile
A
ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC).
M Roupret, A Bertaut, G Pignot, Y Neuzillet, N Houede

Ann Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
French recommendations of the AFU Oncology Committee for Bladder Cancer: Update 2025.
Mathieu Roumiguié, Evanguelos Xylinas, Pierre Etienne Gabriel, Yves Allory, François Audenet, Yann Neuzillet

Fr J Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Systematic Collection of Data for Patient-reported Outcome and Experience Measures Reveals Real-world Recovery Trajectories After Robot-assisted Radical Prostatectomy.
Arthur Peyrottes, Charles Dariane, Laurent Brureau, Stéphane Lorin, Gilles Pasticier, Yann Neuzillet

Eur Urol Focus· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introducing the Sustainable Urology Recommendations Score: Weighing Environmental Impact Within Urological Guidelines.
Maxime Pattou, Elliot Tokarski, Chris Bangma, Yann Neuzillet, Benjamin Pradere

Eur Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy.
Emily Rinderknecht, Francesco Claps, Peter J Bostrom, Shahrokh F Shariat, Yann Neuzillet

World J Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis